BABA vs CALY

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

CALY exhibits a severe disconnect between its current market price ($15.31) and its deterministic value, with a Piotroski F-Score of 4/9 indicating only marginal stability. The stock trades at a massive premium to its Graham Number ($7.29) and Intrinsic Value ($1.47), while facing catastrophic revenue declines (-60.20% YoY). Despite a strong 1-year price rally, the underlying fundamentals—specifically negative profit margins and a critical liquidity shortage (Quick Ratio 0.24)—suggest the current valuation is speculative rather than fundamental.